5 analysts have expressed a variety of opinions on Adaptive Biotechnologies (NASDAQ:ADPT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Range Biotechnologies – a proteomics-focused biotech company that has developed an innovative translational platform to enable better diagnostics and faster drug development – announced recently that ...

Adaptive Biotechnologies (NASDAQ:ADPT) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of ...

Offers immunosequencing platforms (immunoSEQ), clinical diagnostics (clonoSEQ, T-Detect), and research tools for immune system profiling, with revenue primarily generated from product sales and ...

Cell engineering platform company Portal Biotechnologies announced a $5 million pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. Armon Sharei, Ph.D., the founder ...

View Adaptive Biotechnologies Corp. ADPT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Adaptive Biotechnologies (ADPT) shares ended the last trading session 5.8% higher at $13.17. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...